ArticleFrontiers in immunology2022

Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies.

Adrian Rice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.